Výsledky vyhledávání - "Schattenkirchner M"

Vorschlag einer MR-Stadieneinteilung der frühen rheumatoiden Arthritis an den Metakarpophalangeal- und proximalen Interphalangealgelenken

Autor: Krüger K, Pfluger T, Scheck Rj, Schattenkirchner M, Hoischen Sh, Willemsen Uf, Klaus Hahn, Küffer G

Publikováno v: RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 166:215-220

PURPOSE MRI can demonstrate pathology of joint disease in the early course of rheumatoid arthritis prior to destructions seen on conventional radiographs. In a prospective study, we tried to develop a systematical classification of joint pathology de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8234c804c03ae873d333318ceffde31c
https://doi.org/10.1055/s-2007-1015412

Zobrazit plný text záznamu

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: A 12 week, phase II study

Autor: Van De Putte, L.B.A. Rau, R. Breedveld, F.C. Kalden, J.R. Malaise, M.G. Van Riel, P.L.C.M. Schattenkirchner, M. Emery, P. Burmester, G.R. Zeidler, H. Moutsopoulos, H.M. Beck, K. Kupper, H.

Objectives: To evaluate efficacy, dose response, safety, and tolerability of adalimumab (D2E7) in disease modifying antirheumatic drug (DMARD) refractory patients with longstanding, active rheumatoid arthritis (RA). Methods: During a 12 week, double

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::1cda3bbd6848df2a244f5a8b815b1021
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3002275

Zobrazit plný text záznamu

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis

Autor: Alfons den Broeder, van de Putte L, Rau R, Schattenkirchner M, Van Riel P, Sander O, Binder C, Fenner H, Bankmann Y, Velagapudi R, Kempeni J, Kupper H

Publikováno v: The Journal of Rheumatology, 29, 11, pp. 2288-98
The Journal of Rheumatology, 29, 2288-98
Publons
Europe PubMed Central

Item does not contain fulltext OBJECTIVE: To assess the pharmacokinetics, safety profile, and efficacy of the fully human anti-tumor necrosis factor-alpha (anti-TNF-alpha) monoclonal antibody adalimumab (D2E7) in patients with long-standing, active r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::02a2bcf6b82b31f9b54b59ec38c72717
https://hdl.handle.net/2066/142771

Zobrazit plný text záznamu

Long-term safety of ketoprofen in an elderly population of arthritic patients

Autor: Schattenkirchner M

Publikováno v: Scandinavian journal of rheumatology. Supplement. 91

A total of 823 patients (620 women and 203 men) aged greater than or equal to 65 years (mean age: 72 years) with osteoarthritis (n = 642) or rheumatoid arthritis (n = 181) were enrolled in an international prospective study designed to assess the saf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331eda791ccd78efd2c1ba84ec967507
https://pubmed.ncbi.nlm.nih.gov/1771393

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání